Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004855 220001912 1.77 68 Adjuvant (A) 2017-08-25 2017-08-29 AML17 TRIAL 02 N 220026936 AML17 TRIAL
220004856 220001912 null 64.2 Curative (C) 2016-07-15 2016-07-15 AML17 TRIAL 01 null 220026936 AML17 TRIAL
220004857 220001912 1.45 null Palliative (P) null 2016-04-01 Cytarabine low (10to20mg/m2) IV/SC 2 Y 220026936 CYTARABINE
220004858 220001912 1.65 54.1 Disease modification (D) 2014-08-09 2014-09-25 LI-1 TRIAL Y N 220026936 TRIAL
220004862 220001914 1.49 76 Curative (C) 2017-06-21 2017-06-21 AML17 TRIAL Y N 220026952 AML17 TRIAL
220004863 220001914 null 77.4 Curative (C) 2016-06-11 2016-06-20 AML17 TRIAL 2 null 220026952 AML17 TRIAL
220004864 220015868 null 86.5 Palliative (P) 2013-05-08 2013-05-08 LI-1 TRIAL 01 N 220026958 TRIAL
220004865 220001915 null 92 Curative (C) 2016-07-07 2016-07-07 Trial Unspecified Y N 220026960 TRIAL
220004866 220010992 1.55 null Curative (C) 2016-11-10 2016-11-12 Trial Unspecified Y null 220026961 TRIAL
220004867 220010992 1.8 77 Palliative (P) 2015-09-29 2015-10-04 Trial Unspecified Y null 220026961 TRIAL
220004868 220010992 1.75 83.9 Curative (C) 2013-03-18 2013-03-19 AML17 TRIAL Y N 220026961 AML17 TRIAL
220004871 220001917 1.62 38 Curative (C) 2015-08-12 2015-08-12 AML17 TRIAL N N 220026968 AML17 TRIAL
220004873 220001919 1.63 null Palliative (P) 2016-09-19 2016-09-19 Trial Unspecified Y N 220026971 TRIAL
220004874 220001919 1.65 null Not known (9) 2016-11-18 2016-11-18 AML17 TRIAL 02 N 220026971 AML17 TRIAL
220004875 220001919 1.71 116 Curative (C) 2015-11-16 2015-11-16 AML17 TRIAL null N 220026971 AML17 TRIAL
220004876 220001919 1.65 null null null 2013-05-10 CYTARABINE null null 220026971 CYTARABINE
220004877 220001919 1.63 60.9 null 2015-06-18 2015-06-22 AML17 TRIAL 2 N 220026971 AML17 TRIAL
220004878 220001919 1.76 null Palliative (P) 2014-01-11 2014-01-23 CYTARABINE null N 220026971 CYTARABINE
220004879 220001919 1.57 null Curative (C) 2015-03-30 2015-03-30 AML17 TRIAL N null 220026971 AML17 TRIAL
220004880 220001919 null null Palliative (P) 2016-02-04 2016-02-04 Cytarabine Low Dose N N 220026971 CYTARABINE
220004881 220001920 null 76 Not known (9) null 2015-03-14 AML17 TRIAL null null 220026990 AML17 TRIAL
220004882 220001920 1.52 73 Curative (C) 2014-05-17 2014-05-17 Trial Unspecified 1 N 220026990 TRIAL
220004883 220001920 0 81.4 Not known (9) 2013-10-12 2013-10-19 AML17 TRIAL Y N 220026990 AML17 TRIAL
220004884 220001921 1.64 null Palliative (P) 2016-04-11 2016-04-14 CYTARABINE null N 220026998 CYTARABINE
220004885 220001921 1.77 68.8 Radical (R) 2015-04-27 2015-04-30 AML17 TRIAL 1 N 220026998 AML17 TRIAL
220004886 220001922 null 50.6 Palliative (P) 2013-05-05 2013-05-06 Cytarabine Low Dose 01 N 220027001 CYTARABINE
220004887 220001922 null null Curative (C) 2016-08-27 2016-08-27 AML17 TRIAL 01 N 220027001 AML17 TRIAL
220004888 220001922 1.7 null Curative (C) 2014-11-23 2014-11-23 AML17 TRIAL 1 null 220027001 AML17 TRIAL
220004889 220001923 1.68 73 null 2016-12-03 2016-12-03 AML17 TRIAL 01 null 220027011 AML17 TRIAL
220004890 220001924 0 null null 2013-08-25 2013-09-08 Cytarabine Low Dose null N 220027013 CYTARABINE
220004891 220001924 0 65 Not known (9) 2013-12-01 2013-12-03 Cytarabine Low Dose 02 N 220027013 CYTARABINE
220004892 220001924 1.67 null null 2017-03-20 2017-03-28 Cytarabine Low Dose 2 N 220027013 CYTARABINE
220004893 220001925 1.56 71.4 Palliative (P) 2015-12-09 2015-12-09 Trial Unspecified 01 N 220027021 TRIAL
220004894 220001925 1.7 null Palliative (P) 2016-04-04 2016-04-07 Cytarabine Low Dose null null 220027021 CYTARABINE
220004895 220001926 null 88.3 null 2017-06-19 2017-06-19 AML17 TRIAL Y N 220027025 AML17 TRIAL
220004896 220001926 1.62 83.5 Disease modification (D) 2015-06-29 2015-07-02 Trial Unspecified 01 N 220027025 TRIAL
220004897 220001926 null 51.5 Palliative (P) null 2014-05-08 CYTARABINE null null 220027025 CYTARABINE
220004898 220001926 null 73.4 Palliative (P) 2015-12-24 2015-12-24 CYTARABINE 02 null 220027025 CYTARABINE
220004899 220001926 1.79 null Curative (C) 2013-02-24 2013-02-24 AML17 TRIAL N N 220027025 AML17 TRIAL
220004900 220001927 1.88 68.4 Palliative (P) 2015-03-30 2015-04-04 CYTARABINE 02 N 220027032 CYTARABINE
220004901 220001928 1.75 91 Curative (C) 2016-05-30 2016-05-31 AML17 TRIAL 01 N 220027033 AML17 TRIAL
220004902 220001929 null null Palliative (P) null 2014-02-04 CYTARABINE N N 220027034 CYTARABINE
220004903 220001930 null 72.5 Not known (9) 2015-10-20 2015-10-20 Trial Unspecified Y N 220027038 TRIAL
220004904 220001930 1.67 null null null 2013-03-16 CYTARABINE null null 220027038 CYTARABINE
220004905 220001930 1.85 null Curative (C) 2015-01-05 2015-01-06 AML17 TRIAL 02 N 220027038 AML17 TRIAL
220004906 220001930 0 77.8 Disease modification (D) 2014-09-15 2014-09-15 CYTARABINE 02 null 220027038 CYTARABINE
220004907 220001930 1.7 88.3 null 2015-10-31 2015-10-31 Cytarabine Low Dose null N 220027038 CYTARABINE
220004908 220001931 1.79 0 Not known (9) 2013-12-02 2013-12-04 Cytarabine Low Dose 2 N 220027049 CYTARABINE
220004909 220001931 1.65 140 Palliative (P) 2013-04-28 2013-04-28 Trial Unspecified Y N 220027049 TRIAL
220004910 220001931 1.64 null Not known (9) 2015-01-04 2015-01-06 AML17 TRIAL 1 null 220027049 AML17 TRIAL